1. Home
  2. EVTL vs PBYI Comparison

EVTL vs PBYI Comparison

Compare EVTL & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

HOLD

Current Price

$2.16

Market Cap

338.7M

Sector

Industrials

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$7.03

Market Cap

343.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTL
PBYI
Founded
2016
2010
Country
United Kingdom
United States
Employees
454
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
338.7M
343.9M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
EVTL
PBYI
Price
$2.16
$7.03
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$12.70
N/A
AVG Volume (30 Days)
2.8M
234.0K
Earning Date
03-24-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$27,685,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$3.03
52 Week High
$7.60
$7.90

Technical Indicators

Market Signals
Indicator
EVTL
PBYI
Relative Strength Index (RSI) 34.19 47.58
Support Level $1.90 $6.32
Resistance Level $2.89 $7.31
Average True Range (ATR) 0.19 0.23
MACD -0.03 -0.02
Stochastic Oscillator 2.68 51.42

Price Performance

Historical Comparison
EVTL
PBYI

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: